Thrivent Financial for Lutherans reports beneficial ownership of 820,904 shares of John B. Sanfilippo & Son, Inc. common stock, representing 9.07% of the class. This percentage is based on 9,046,833 shares outstanding as of October 23, 2025, per the company’s Form 10‑Q.
Thrivent has sole voting and dispositive power over 3,158 shares held in the Thrivent Defined Benefit Plan Trust, for which it disclaims beneficial ownership, and shared voting and dispositive power over 817,746 shares held by registered investment companies and accounts it advises. The filing states these securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
John B. Sanfilippo & Son, Inc. reported higher sales and earnings for the quarter and first half of fiscal 2026. Quarterly net sales rose to $314.8 million, up 4.6% year over year, while first-half net sales reached $613.5 million, up 6.3%.
Despite lower sales volumes, higher average selling prices and better alignment with commodity costs lifted profitability. Quarterly net income increased to $18.0 million with diluted EPS of $1.53, and first-half net income rose to $36.7 million with diluted EPS of $3.12. Gross margin expanded to 18.8% for the quarter and 18.5% for the first half.
Operating cash flow strengthened to $94.6 million in the first half, supporting $47.3 million of capital spending, including major investments in production capacity and efficiency. Total debt (current and long-term) increased as the company drew $26.2 million on a new equipment loan while reducing revolving credit borrowings to $10.0 million. Inventories grew 14.4% year over year, reflecting higher nut acquisition costs and higher finished goods levels.
John B. Sanfilippo & Son, Inc. filed a current report to note that it issued a press release with financial results. On January 29, 2026, the company released its results for the second quarter and the twenty-six weeks ended December 25, 2025.
The press release is included as Exhibit 99.1 to the report, with an additional Exhibit 104 covering the inline XBRL cover page data file.
John B. Sanfilippo & Son, Inc. (JBSS) reported an insider transaction by an officer on Form 4. The reporting person, who serves as VP, Corporate Controller, disclosed a disposition of 355 shares of JBSS common stock on 11/17/2025 at a price of $68.07 per share. Following this transaction, the officer directly beneficially owns 6,258.99 shares of JBSS common stock. The filing is made by a single reporting person and reflects a routine update to the insider's ownership.
Sanfilippo John B. & Son Inc. (JBSS) insider activity: A senior vice president of human resources reported a routine transaction in company stock. On 11/17/2025, the officer disposed of 485 shares of common stock in a transaction coded "F" at a price of $68.07 per share, which typically indicates shares withheld to cover taxes on an equity award. After this transaction, the officer directly owns 10,050 shares of JBSS common stock.
John B. Sanfilippo & Son, Inc. (JBSS) reported an insider transaction by a director. On 11/17/2025, the reporting person disposed of 355 shares of common stock at a price of $68.07 per share, as shown by transaction code "F". Following this transaction, the director beneficially owns 16,980 shares of JBSS common stock in direct form. The filing is made on Form 4 for a single reporting person and is signed by a power of attorney on 11/18/2025.
John B. Sanfilippo & Son, Inc. (JBSS) reported a Form 4 showing its VP, Corporate Controller acquired 1,300 restricted stock units on 11/12/2025 under the 2023 Omnibus Incentive Plan at a price of $0 per unit. Each unit converts into one share upon vesting, which is scheduled for 11/12/2028, subject to conditions.
Following the reported transaction, the officer beneficially owned 6,613.99 shares of JBSS common stock directly.
John B. Sanfilippo & Son (JBSS) reported an insider equity grant. The CFO & EVP, Finance and Admin received 6,500 restricted stock units on 11/12/2025 at a reported price of $0. Each RSU represents one share upon vesting. Subject to conditions, the RSUs are scheduled to vest on 11/12/2028, with settlement generally in an equivalent number of common shares on that date. Following this grant, the reporting person’s beneficial ownership is 35,298 shares (direct). This is a routine Form 4 disclosure of a compensatory award.
John B. Sanfilippo & Son, Inc. (JBSS) reported a director equity grant on a Form 4. On 11/12/2025, the reporting person acquired 1,625 restricted stock units at $0 per unit. Each unit represents the right to receive one common share upon vesting.
The RSUs are scheduled to vest on November 12, 2028, subject to conditions, and are generally payable in an equivalent number of shares on the same date. Following the transaction, the reporting person beneficially owns 17,335 shares, held directly.
John B. Sanfilippo & Son, Inc. (JBSS) reported an insider equity award. The CEO, who is also a Director and 10% Owner, acquired 11,819 restricted stock units on 11/12/2025 at a stated price of $0.
These RSUs were granted under the company’s 2023 Omnibus Incentive Plan. Each unit represents the right to receive one share of common stock upon vesting. Subject to conditions, the units are scheduled to vest on 11/12/2028 and, once vested, are generally eligible to be paid in an equivalent number of shares on that date.
Following this transaction, the reporting person’s direct beneficial ownership is disclosed as 36,260 shares.